Cancer, Cancer Drug | featured news

Cancer Physicians Attack High Drug Costs

More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering.

 

FDA approves new targeted breast cancer drug

Roche

The Food and Drug Administration says it has approved a new form of a best-selling breast cancer drug that targets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY'-luh) from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a double-shot of anti-tumor poison.

 

Breast cancer drug raises risk of heart problems in older women

The breast cancer drug Herceptin increases the risk of heart problems in elderly patients, especially those with a history of heart disease and/or ...

 

FDA to hear appeal on breast cancer drug Avastin

The best-selling cancer drug in the world comes under federal scrutiny as drugmaker Roche makes a last-ditch effort to keep Avastin approved ...

 

$93,000 cancer drug: How much is a life worth?

$93,000 cancer drug: How much is a life worth?

Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth.

 

FDA approves cancer drug for dogs

The U.S. Food and Drug Administration has approved the first drug made specifically to treat cancer in dogs.

 

Subscribe to this RSS topic: Syndicate content